tiprankstipranks

My stock portfolio - New Portfolio

Lubos Novotny

My stock portfolio
Individual Investor
Ranked #530,771 out of 859,402 TipRanks' Investors
Success Rate
46%
28 out of 61
profitable transactions
Average Return
0.96%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 1.94%
6-Month Return-
12-Month Return-
YTD Return▼ 12.18%
Total Return▼ 12.20%

Best Trade

Opened at
Closed at-
Gain▲ 226.58%

Bio

High-conviction biotech growth portfolio with selective optionality bets.

Performance

16.47%0-16.47%
▲ 12.88%
▲ 3.56%
Sep 2025
▲ 10.96%
▲ 2.38%
Oct 2025
▼ 3.68%
▲ 0.19%
Nov 2025
▼ 0.10%
▲ 0.08%
▼ 0.01%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 0.07%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 4.59%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 16.47%
Mar 2026
▲ 13.18%
▲ 7.89%
▲ 10.10%
Apr 2026
TipRanks AverageS&P 500Investor Portfolio
▲ 12.88%▲ 3.56%
▲ 10.96%▲ 2.38%
▼ 3.68%▲ 0.19%
▼ 0.10%▲ 0.08%▼ 0.01%
▲ 4.06%▲ 1.47%▲ 0.07%
▼ 1.12%▼ 0.86%▼ 4.59%
▲ 0.60%▼ 4.94%▼ 16.47%
▲ 13.18%▲ 7.89%▲ 10.10%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Nektar Therapeutics
▲ 43.04%
3
Close
Apr 07, 2026
Veritone
2.43%
▼ 43.69%
5
Buy
Mar 26, 2026
ImmunityBio
29.13%
▲ 71.63%
12
Buy
Mar 24, 2026
Omeros
12.6%
▲ 7.75%
8
Buy
Mar 16, 2026
60 Degrees Pharmaceuticals, Inc.
4.73%
▼ 40.55%
1
Open
Mar 12, 2026
Century Therapeutics
▲ 1.21%
3
Close
Mar 10, 2026
Tenaya Therapeutics
7.87%
▼ 2.78%
3
Buy
Mar 05, 2026
ABVC BioPharma
▼ 4.73%
2
Close
Mar 04, 2026
GeoVax Labs
▼ 27.08%
6
Close
Feb 26, 2026
DeFi Development Corporation
4.22%
▲ 13.30%
1
Open
Feb 25, 2026
Banco Comercial Portugues
▲ 3.59%
2
Close
Feb 19, 2026
AC Immune SA
▼ 3.09%
10
Close
Feb 06, 2026
AGNC Investment
▲ 12.80%
3
Close
Feb 06, 2026
Petroleo Brasileiro SA- Petrobras
▲ 26.22%
5
Close
Feb 06, 2026
Two Harbors
▲ 32.54%
4
Close
Jan 29, 2026
Abeona Therapeutics
5.53%
▲ 4.50%
4
Buy
Jan 29, 2026
Orchid Island Capital
▲ 15.69%
3
Close
Jan 22, 2026
Marker Therapeutics
1.69%
▼ 12.02%
2
Sell
Jan 21, 2026
BlackRock TCP Capital
▼ 3.60%
4
Close
Jan 08, 2026
Acrivon Therapeutics, Inc.
6.98%
▼ 28.43%
2
Buy
Jan 08, 2026